Insight Molecular Diagnostics Return on Investment 2014-2026 | IMDX
Current and historical return on investment (ROI) values for Insight Molecular Diagnostics (IMDX) over the last 10 years.
| Insight Molecular Diagnostics ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2026-06-30 | $-0.05B | $-0.01B | 392.00% |
| 2026-03-31 | $-0.05B | $-0.01B | 640.00% |
| 2025-12-31 | $-0.05B | $-0.01B | 1133.33% |
| 2025-09-30 | $-0.06B | $0.01B | -620.00% |
| 2025-06-30 | $-0.07B | $0.01B | -650.00% |
| 2025-03-31 | $-0.06B | $0.01B | -600.00% |
| 2024-12-31 | $-0.06B | $0.01B | -885.71% |
| 2024-09-30 | $-0.04B | 0 | 0.00% |
| 2024-06-30 | $-0.04B | 0 | 0.00% |
| 2024-03-31 | $-0.04B | 0 | 0.00% |
| 2023-12-31 | $-0.03B | 0 | 0.00% |
| 2023-09-30 | $-0.02B | 0 | 0.00% |
| 2023-06-30 | $-0.02B | 0 | 0.00% |
| 2023-03-31 | $-0.01B | 0 | 0.00% |
| 2022-12-31 | $-0.02B | 0 | 0.00% |
| 2022-09-30 | $-0.02B | 0 | 0.00% |
| 2022-06-30 | $-0.03B | $0.03B | -136.00% |
| 2022-03-31 | $-0.05B | $0.05B | -90.64% |
| 2021-12-31 | $-0.05B | $0.08B | -69.45% |
| 2021-09-30 | $-0.05B | $0.09B | -52.02% |
| 2021-06-30 | $-0.04B | $0.07B | -51.57% |
| 2021-03-31 | $-0.03B | $0.06B | -56.64% |
| 2020-12-31 | $-0.03B | $0.04B | -74.36% |
| 2020-09-30 | $-0.03B | $0.04B | -80.52% |
| 2020-06-30 | $-0.03B | $0.04B | -83.92% |
| 2020-03-31 | $-0.03B | $0.03B | -77.04% |
| 2019-12-31 | $-0.02B | $0.03B | -65.19% |
| 2019-09-30 | $-0.02B | $0.03B | -67.92% |
| 2019-06-30 | $-0.02B | $0.02B | -76.19% |
| 2019-03-31 | $-0.02B | $0.02B | -103.45% |
| 2018-12-31 | $-0.02B | $0.01B | -200.00% |
| 2018-09-30 | $-0.02B | $0.01B | -187.50% |
| 2018-06-30 | $-0.02B | $0.01B | -223.53% |
| 2018-03-31 | $-0.02B | $0.01B | -230.30% |
| 2017-12-31 | $-0.02B | $0.01B | -235.29% |
| 2017-09-30 | $-0.02B | $0.01B | -200.00% |
| 2017-06-30 | $-0.02B | $0.01B | -146.34% |
| 2017-03-31 | $-0.01B | $0.01B | -143.59% |
| 2016-12-31 | $-0.01B | $0.01B | -171.43% |
| 2016-09-30 | $-0.01B | $0.01B | -288.89% |
| 2016-06-30 | $-0.01B | $0.00B | -960.00% |
| 2016-03-31 | $-0.01B | 0 | 0.00% |
| 2015-12-31 | $-0.01B | 0 | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.132B | $0.004B |
| Insight Molecular Diagnostics Inc. is a pioneering diagnostics technology company. Insight Molecular Diagnostics Inc., formerly known as Oncocyte Corporation, is based in NASHVILLE, Tenn. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $43.014B | 42.92 |
| Tempus AI (TEM) | United States | $11.225B | 0.00 |
| 10x Genomics (TXG) | United States | $9.135B | 0.00 |
| Hinge Health (HNGE) | United States | $7.649B | 73.48 |
| Hims & Hers Health (HIMS) | United States | $6.722B | 0.00 |
| Doximity (DOCS) | United States | $4.704B | 29.00 |
| Heartflow (HTFL) | United States | $4.308B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $3.782B | 249.39 |
| Clover Health Investments (CLOV) | United States | $2.709B | 0.00 |
| Privia Health (PRVA) | United States | $2.667B | 99.43 |
| Inspire Medical Systems (INSP) | United States | $2.149B | 32.74 |
| Butterfly Network (BFLY) | United States | $1.973B | 0.00 |
| Schrodinger (SDGR) | United States | $1.532B | 0.00 |
| Omnicell (OMCL) | United States | $1.524B | 21.76 |
| Azenta (AZTA) | United States | $1.404B | 76.29 |
| Enovis (ENOV) | United States | $1.051B | 5.44 |
| Talkspace (TALK) | United States | $0.879B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.659B | 0.00 |
| Phreesia (PHR) | United States | $0.647B | 34.73 |
| Claritev (CTEV) | United States | $0.618B | 0.00 |
| Veradigm (MDRX) | United States | $0.593B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.568B | 0.00 |
| Evolent Health (EVH) | United States | $0.464B | 0.00 |
| Carlsmed (CARL) | United States | $0.419B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.370B | 0.00 |
| CapsoVision (CV) | United States | $0.326B | 0.00 |
| Standard BioTools (LAB) | United States | $0.273B | 0.00 |
| American Well (AMWL) | United States | $0.230B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.144B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.137B | 0.00 |
| CareCloud (CCLD) | United States | $0.089B | 6.53 |
| Pulmonx (LUNG) | United States | $0.085B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.065B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.062B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.060B | 0.00 |
| Outset Medical (OM) | United States | $0.059B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.050B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.035B | 0.00 |
| 111 (YI) | China | $0.031B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.026B | 0.00 |
| HeartBeam (BEAT) | United States | $0.023B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| HeartSciences (HSCS) | United States | $0.014B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.009B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| DataMeds AI (MEDS) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| PROFUSA (PFSA) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |
| Zhongchao (ZCMD) | China | $0.001B | 0.00 |
| TruBridge (TBRG) | United States | $0.000B | 0.00 |